Found 2 hits Enz. Inhib. hit(s) with Target = 'Neuropeptide Y receptor type 2' and Ligand = 'BDBM50197023' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50197023
((2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-...)Show SMILES COc1cc(ccc1N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O |wU:76.78,77.81,45.47,94.96,23.23,61.63,114.116,wD:69.71,33.34,12.12,83.85,53.55,103.105,(-10.19,-15.44,;-8.86,-16.2,;-7.52,-15.43,;-6.19,-16.19,;-4.87,-15.42,;-4.86,-13.88,;-6.2,-13.11,;-7.53,-13.88,;-8.87,-13.11,;-3.53,-16.18,;-3.53,-17.72,;-2.21,-15.4,;-.87,-16.16,;-.87,-17.7,;.46,-18.47,;.46,-20.01,;1.79,-20.78,;1.8,-22.32,;.45,-23.09,;3.11,-23.09,;.46,-15.39,;.46,-13.85,;1.79,-16.16,;3.13,-15.4,;3.13,-13.86,;4.46,-13.09,;5.87,-13.72,;6.9,-12.57,;6.13,-11.24,;4.62,-11.56,;4.46,-16.17,;4.46,-17.71,;5.79,-15.39,;7.12,-16.16,;7.12,-17.7,;8.45,-18.47,;9.79,-17.7,;11.12,-18.47,;11.12,-20.01,;12.43,-20.77,;9.79,-20.78,;8.45,-20.01,;8.45,-15.39,;8.45,-13.85,;9.78,-16.16,;11.12,-15.4,;11.12,-13.86,;12.45,-13.09,;12.45,-11.55,;13.79,-13.86,;12.45,-16.17,;12.45,-17.71,;13.78,-15.39,;15.11,-16.16,;15.11,-17.7,;16.44,-18.47,;17.77,-17.69,;16.44,-20.01,;16.44,-15.39,;16.44,-13.85,;17.78,-16.16,;19.12,-15.39,;19.12,-13.85,;20.44,-13.08,;20.44,-11.54,;21.78,-13.85,;20.44,-16.16,;20.44,-17.7,;21.78,-15.39,;23.11,-16.16,;23.11,-17.7,;24.44,-18.47,;21.77,-18.47,;24.44,-15.39,;24.44,-13.85,;25.77,-16.16,;27.11,-15.39,;27.11,-13.85,;25.77,-13.08,;28.43,-13.07,;28.44,-16.16,;28.44,-17.7,;29.77,-15.38,;31.1,-16.16,;31.1,-17.7,;32.43,-18.47,;32.43,-20.01,;33.76,-20.77,;33.76,-22.31,;32.43,-23.07,;35.1,-23.07,;32.43,-15.39,;32.43,-13.85,;33.76,-16.15,;35.1,-15.39,;35.1,-13.85,;36.43,-13.08,;36.43,-11.54,;35.1,-10.76,;37.77,-10.77,;36.43,-16.16,;36.43,-17.7,;37.76,-15.39,;39.09,-16.16,;39.09,-17.7,;40.42,-18.47,;40.42,-20.01,;41.76,-20.77,;41.76,-22.31,;40.42,-23.08,;43.09,-23.08,;40.42,-15.39,;40.42,-13.85,;41.76,-16.16,;43.09,-15.39,;43.09,-13.85,;44.42,-13.08,;45.76,-13.85,;47.09,-13.08,;47.09,-11.54,;48.42,-10.77,;45.76,-10.77,;44.42,-11.54,;44.42,-16.16,;45.76,-15.39,;44.42,-17.7,)| Show InChI InChI=1S/C80H123N27O19/c1-39(2)30-55(101-72(120)57(33-44-17-22-48(110)23-18-44)103-73(121)58(35-46-37-91-38-95-46)104-69(117)50(12-9-27-92-78(85)86)96-66(114)45-19-24-49(81)60(34-45)126-8)71(119)105-59(36-62(83)112)74(122)102-56(31-40(3)4)75(123)106-63(41(5)6)76(124)107-64(42(7)108)77(125)99-52(14-11-29-94-80(89)90)67(115)98-53(25-26-61(82)111)70(118)97-51(13-10-28-93-79(87)88)68(116)100-54(65(84)113)32-43-15-20-47(109)21-16-43/h15-24,34,37-42,50-59,63-64,108-110H,9-14,25-33,35-36,81H2,1-8H3,(H2,82,111)(H2,83,112)(H2,84,113)(H,91,95)(H,96,114)(H,97,118)(H,98,115)(H,99,125)(H,100,116)(H,101,120)(H,102,122)(H,103,121)(H,104,117)(H,105,119)(H,106,123)(H,107,124)(H4,85,86,92)(H4,87,88,93)(H4,89,90,94)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,63+,64+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharmaceuticals Corporation
Curated by ChEMBL
| Assay Description
Displacement of human [125I]PYY from NPY2 receptor expressed in human KAN-TS cells |
Bioorg Med Chem Lett 17: 538-41 (2007)
Article DOI: 10.1016/j.bmcl.2006.10.007
BindingDB Entry DOI: 10.7270/Q2959H6F |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50197023
((2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-...)Show SMILES COc1cc(ccc1N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O |wU:76.78,77.81,45.47,94.96,23.23,61.63,114.116,wD:69.71,33.34,12.12,83.85,53.55,103.105,(-10.19,-15.44,;-8.86,-16.2,;-7.52,-15.43,;-6.19,-16.19,;-4.87,-15.42,;-4.86,-13.88,;-6.2,-13.11,;-7.53,-13.88,;-8.87,-13.11,;-3.53,-16.18,;-3.53,-17.72,;-2.21,-15.4,;-.87,-16.16,;-.87,-17.7,;.46,-18.47,;.46,-20.01,;1.79,-20.78,;1.8,-22.32,;.45,-23.09,;3.11,-23.09,;.46,-15.39,;.46,-13.85,;1.79,-16.16,;3.13,-15.4,;3.13,-13.86,;4.46,-13.09,;5.87,-13.72,;6.9,-12.57,;6.13,-11.24,;4.62,-11.56,;4.46,-16.17,;4.46,-17.71,;5.79,-15.39,;7.12,-16.16,;7.12,-17.7,;8.45,-18.47,;9.79,-17.7,;11.12,-18.47,;11.12,-20.01,;12.43,-20.77,;9.79,-20.78,;8.45,-20.01,;8.45,-15.39,;8.45,-13.85,;9.78,-16.16,;11.12,-15.4,;11.12,-13.86,;12.45,-13.09,;12.45,-11.55,;13.79,-13.86,;12.45,-16.17,;12.45,-17.71,;13.78,-15.39,;15.11,-16.16,;15.11,-17.7,;16.44,-18.47,;17.77,-17.69,;16.44,-20.01,;16.44,-15.39,;16.44,-13.85,;17.78,-16.16,;19.12,-15.39,;19.12,-13.85,;20.44,-13.08,;20.44,-11.54,;21.78,-13.85,;20.44,-16.16,;20.44,-17.7,;21.78,-15.39,;23.11,-16.16,;23.11,-17.7,;24.44,-18.47,;21.77,-18.47,;24.44,-15.39,;24.44,-13.85,;25.77,-16.16,;27.11,-15.39,;27.11,-13.85,;25.77,-13.08,;28.43,-13.07,;28.44,-16.16,;28.44,-17.7,;29.77,-15.38,;31.1,-16.16,;31.1,-17.7,;32.43,-18.47,;32.43,-20.01,;33.76,-20.77,;33.76,-22.31,;32.43,-23.07,;35.1,-23.07,;32.43,-15.39,;32.43,-13.85,;33.76,-16.15,;35.1,-15.39,;35.1,-13.85,;36.43,-13.08,;36.43,-11.54,;35.1,-10.76,;37.77,-10.77,;36.43,-16.16,;36.43,-17.7,;37.76,-15.39,;39.09,-16.16,;39.09,-17.7,;40.42,-18.47,;40.42,-20.01,;41.76,-20.77,;41.76,-22.31,;40.42,-23.08,;43.09,-23.08,;40.42,-15.39,;40.42,-13.85,;41.76,-16.16,;43.09,-15.39,;43.09,-13.85,;44.42,-13.08,;45.76,-13.85,;47.09,-13.08,;47.09,-11.54,;48.42,-10.77,;45.76,-10.77,;44.42,-11.54,;44.42,-16.16,;45.76,-15.39,;44.42,-17.7,)| Show InChI InChI=1S/C80H123N27O19/c1-39(2)30-55(101-72(120)57(33-44-17-22-48(110)23-18-44)103-73(121)58(35-46-37-91-38-95-46)104-69(117)50(12-9-27-92-78(85)86)96-66(114)45-19-24-49(81)60(34-45)126-8)71(119)105-59(36-62(83)112)74(122)102-56(31-40(3)4)75(123)106-63(41(5)6)76(124)107-64(42(7)108)77(125)99-52(14-11-29-94-80(89)90)67(115)98-53(25-26-61(82)111)70(118)97-51(13-10-28-93-79(87)88)68(116)100-54(65(84)113)32-43-15-20-47(109)21-16-43/h15-24,34,37-42,50-59,63-64,108-110H,9-14,25-33,35-36,81H2,1-8H3,(H2,82,111)(H2,83,112)(H2,84,113)(H,91,95)(H,96,114)(H,97,118)(H,98,115)(H,99,125)(H,100,116)(H,101,120)(H,102,122)(H,103,121)(H,104,117)(H,105,119)(H,106,123)(H,107,124)(H4,85,86,92)(H4,87,88,93)(H4,89,90,94)/t42-,50+,51+,52+,53+,54+,55+,56+,57+,58+,59+,63+,64+/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
Bayer Pharmaceuticals Corporation
Curated by ChEMBL
| Assay Description
Agonist activity at human NPY2 receptor expressed in human KAN-TS cells by [35S]GTPgammaS incorporation assay |
Bioorg Med Chem Lett 17: 538-41 (2007)
Article DOI: 10.1016/j.bmcl.2006.10.007
BindingDB Entry DOI: 10.7270/Q2959H6F |
More data for this
Ligand-Target Pair | |
Search and Browse
